HOPA Strategic Plan

HOPA 2026 meeting photo

2026-2031 Strategic Plan

Building on the momentum of its previous strategic plan, the Hematology/Oncology Pharmacy Association (HOPA) is proud to introduce its new five-year strategic plan for 2026-2031, with implementation beginning in June 2026.

Guided by the HOPA Board of Directors and developed in close collaboration with staff, members, stakeholders, and planning partners at 2B Communications & Strategy Group, this plan reflects a thoughtful and inclusive process grounded in listening, reflection, and strategic alignment. Insights gathered through stakeholder interviews, operational performance trends, member feedback, and collaborative planning sessions informed the priorities that will guide HOPA into its next chapter.

The 2026-2031 strategic plan introduces updated strategic pillars along with new goals and strategies designed to move HOPA forward with clarity, agility, and purpose.

Strategic Pillars

Our Vision

All individuals affected by cancer have a hematology/oncology pharmacist as an integral member of their care team.

Our Mission

Support pharmacy practitioners and promote and advance hematology/oncology pharmacy to optimize the care of individuals affected by cancer.

Core Values: We Are HOPA

While our Vision and Mission remain unchanged, our strategic planning process led to newly revised core values.

core-values-graphic-final

Patients First: Our Purpose.

  • We place the needs and outcomes of people with cancer at the center of each decision and action.
  • We champion access to safe, effective, and innovative cancer therapies for all patients.

Integrity Without Exception: Our Principles.

  • We conduct our work with transparency, accountability, and an unwavering commitment to ethical practice.
  • We honor the trust placed in us as oncology pharmacists by upholding the highest standards of professionalism.

Passion for Progress: Innovation.

  • We advance our profession through research, education, and practice advancement.
  • We leverage our collective strengths and collaborative partnerships to drive oncology pharmacy practice.
  • We translate emerging evidence into real-world practice to improve cancer cancer and patient outcomes.

Lead Boldly: Leadership.

  • Our expertise shapes the future of oncology pharmacy and improves care for people with cancer.
  • We challenge the status quo and turn ideas into action that strengthens the profession and patient care.
  • We advocate for policies and partnerships that elevate the role of oncology pharmacists and advance outcomes for patients.

Foster Community: Belonging.

  • We create a professional home within HOPA where oncology pharmacists connect, support one another, and thrive.
  • We are stronger and more effective when we bring varied voices and experiences together to advance cancer care.

2026-2031 HOPA Strategic Plan